BP
Therapeutic Areas
Optimeos Life Sciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Hepatic Gene Replacement | Citrullinemia Type 1 | Pre-clinical |
| In Vivo T Cell Engineering | Autoimmune Diseases & Cancer | Research |
| Long-acting GLP-1 Depot | Obesity/Metabolic Diseases | Pre-clinical |
Leadership Team at Optimeos Life Sciences
SH
Shahram Hejazi, PhD
Founding CEO
GH
Gregory Harriman, MD
CMO
JS
Jason Smith, PhD
HEAD OF BUSINESS DEVELOPMENT
RP
Rob Pagels, PhD
Senior Director of R&D
CM
Chet Markwalter, PhD
SENIOR DIRECTOR OF SCIENTIFIC OPERATIONS
ME
Mark Esposito, PhD
Senior Director of Biology